BioPharmX
Menlo Park
About BioPharmX
BioPharmX, Inc. provides innovative drug-delivery products through its unique, patented platform technologies for pharmaceutical and OTC applications. Its products are designed to address unmet needs in large, well-defined and under-served markets in the fast growing health and wellness markets, including dermatology, women's health and Ear, Nose and Throat (ENT) therapy. The BioPharmX management team consists of Silicon Valley executives, scientists and business professionals combining large company discipline with deep bio-tech expertise focused on drug delivery and molecular properties. Technical expertise includes pharmaceutical, biological sciences, medical devices and consumer product development with extensive experience in ex vivo/in vitro design, preclinical and clinical development, as well as intellectual property generation. Quality and regulatory expertise includes knowledge of medical directives, US FDA guidance for drugs and medical devices and ICH & IEC guidelines for the US, Canada. China and European Union.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $20.4M
- Funding stage: IPO
- Last round: Series A (Mar 2015)
- Ticker: nysemkt:BPMX
- Website: biopharmx.com
- Phone: (650) 889-5020
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/biopharmx-1415416 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.